A. KAZĞAN KILIÇASLAN Et Al. , "Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study," Medicine Science , vol.10, no.3, pp.860-867, 2021
KAZĞAN KILIÇASLAN, A. Et Al. 2021. Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study. Medicine Science , vol.10, no.3 , 860-867.
KAZĞAN KILIÇASLAN, A., YILDIZ, S., KURT, O., & KORKMAZ, S., (2021). Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study. Medicine Science , vol.10, no.3, 860-867.
KAZĞAN KILIÇASLAN, ASLI Et Al. "Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study," Medicine Science , vol.10, no.3, 860-867, 2021
KAZĞAN KILIÇASLAN, ASLI K. Et Al. "Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study." Medicine Science , vol.10, no.3, pp.860-867, 2021
KAZĞAN KILIÇASLAN, A. Et Al. (2021) . "Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study." Medicine Science , vol.10, no.3, pp.860-867.
@article{article, author={ASLI KAZĞAN KILIÇASLAN Et Al. }, title={Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study}, journal={Medicine Science}, year=2021, pages={860-867} }